Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

The efficacy of the first schedule of COVID-19 mRNA vaccines has decreased after the surge of the Delta variant, posing the need to administer a booster dose to enhance the neutralising immune response. This study aims at evaluating the duration of protection given by the booster dose of Pfizer–BioN...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascucci, Domenico, Grossi, Adriano, Lontano, Alberto, Marziali, Eleonora, Nurchis, Mario Cesare, Grassi, Vincenzo Maria, Raponi, Matteo, Vetrugno, Giuseppe, Capelli, Giovanni, Calabrò, Giovanna Elisa, Staiti, Domenico, Sanguinetti, Maurizio, Damiani, Gianfranco, Laurenti, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863759/
https://www.ncbi.nlm.nih.gov/pubmed/36679868
http://dx.doi.org/10.3390/vaccines11010025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863759/
https://www.ncbi.nlm.nih.gov/pubmed/36679868
http://dx.doi.org/10.3390/vaccines11010025

Ejemplares similares